Clinical implications of Golgi protein 73 and granulocyte colony-stimulating factor and their related factors in children with bronchopneumonia

被引:1
|
作者
Li, Baofa [1 ]
Liu, Xin [1 ]
机构
[1] Ningbo Women & Childrens Hosp, Dept Lab, Ningbo 315012, Peoples R China
关键词
Golgi glycoprotein 73; Granulocyte colony-stimulating factor; Bronchopneumonia; Respiratory failure; PNEUMONIA; DIAGNOSIS;
D O I
10.1016/j.jped.2022.05.005
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To investigate the clinical implications of Golgi glycoprotein 73 (GP73) and granulo-cyte colony-stimulating factor (G-CSF) in children with bronchopneumonia (BP).Methods: Seventy-two children with BP (observation group) and 81 healthy children (control group) consecutively brought to the present study's hospital between June 2019 and October 2020 were enrolled. GP73 and G-CSF levels were determined to analyze their diagnostic value for pediatric BP. High-sensitivity C-reactive protein (hs-CRP) was also measured. The clinical implications of GP73 and G-CSF in pediatric BP complicated with respiratory failure and their connections with the inflammatory response were discussed.Results: GP73 and G-CSF levelswere remarkably higherin theobservation group (p< 0.05). The sensitiv-ity and specificity of combined detection (GP73+G-CSF) in predicting pediatric BP were 72.22% and 86.42%, respectively (p < 0.001). GP73 and G-CSF, which are closely related to X-ray classification and complications in the observation group, decreased after treatment and were positively correlated with hs-CRP (p < 0.05), especially in children complicated with respiratory failure. Regression analysisidenti-fied the independence of the course of the disease, hs-CRP, X-ray classification, GP73, and G-CSF as influ-encing factors of respiratoryfailurein children with BP (p < 0.05).Conclusion: GP73 and G-CSF, with elevated levels in children with BP, are strongly linked to dis-ease progression and are independent influencing factors of respiratory failure, which may be the key to diagnosing and treating pediatric BP in the future.(c) 2022 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
引用
收藏
页码:65 / 71
页数:7
相关论文
共 50 条
  • [1] A Bayesian meta-analysis of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in children with cancer
    Sung, L
    Beyene, J
    Hayden, J
    Nathan, PC
    Lange, B
    Tomlinson, GA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (09) : 811 - 817
  • [2] Granulocyte colony-stimulating factor and leukemogenesis
    de Figueiredo, LL
    Lima, RSDE
    Rego, EM
    MEDIATORS OF INFLAMMATION, 2004, 13 (03) : 145 - 150
  • [3] Granulocyte colony-stimulating factor and hypercoagulability
    Kaptan, Kuersat
    Beyan, Cengiz
    Ifran, Ahmet
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 131 (01) : 129 - 129
  • [4] Granulocyte colony-stimulating factor and parathyroid hormone related protein producing bladder cancer
    Kamai, T
    Arai, R
    Takagi, K
    JOURNAL OF UROLOGY, 1999, 161 (05) : 1565 - 1566
  • [5] Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia
    Ohno, R
    LEUKEMIA RESEARCH, 1998, 22 (12) : 1143 - 1154
  • [6] Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein
    Hirasawa, E
    Kitamura, T
    Oka, T
    Matsushita, H
    JOURNAL OF UROLOGY, 2002, 167 (05) : 2130 - 2130
  • [7] Mature and immature myeloid cells decrease the granulocyte colony-stimulating factor level by absorption of granulocyte colony-stimulating factor
    Saito, K
    Nakamura, Y
    Waga, K
    Hirota, K
    Inoue, F
    Enokihara, H
    Nara, N
    Furusawa, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1998, 67 (02) : 145 - 151
  • [8] The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis
    Andres, Emmanuel
    Maloisel, Frederic
    Zimmer, Jacques
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 3 - 8
  • [9] LEVELS OF HUMAN SERUM GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR UNDER PATHOLOGICAL CONDITIONS
    OMORI, F
    OKAMURA, S
    SHIMODA, K
    OTSUKA, T
    HARADA, M
    NIHO, Y
    BIOTHERAPY, 1992, 4 (02) : 147 - 153
  • [10] Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors
    Abraham, Ivo
    Tharmarajah, Soba
    MacDonald, Karen
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (02) : 235 - 246